Home / Companies / Entrada Therapeutics, Inc. / 10 Jun 2026
Entrada Therapeutics, Inc.: meeting of 10 Jun 2026
Votes reported on Form N-PX, item by item
76 Form N-PX filers reported votes at the Entrada Therapeutics, Inc. meeting of 10 Jun 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 59.0% of reported votes for; 32 filers withheld from or voted against at least one nominee.
294 vote records from 75 filers. 26 of the 73 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
147 vote records from 75 filers. 1 of the 73 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
7 vote records from 4 filers. 3 of the 4 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
287 vote records from 75 filers. 65 of the 73 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Entrada Therapeutics, Inc. meeting?
76 Form N-PX filers reported votes at the meeting of 10 Jun 2026. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Entrada Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Entrada Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Entrada Therapeutics, Inc. with a meeting date within three days of 10 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.